Page last updated: 2024-11-08

2-(2-hydroxy-4-methylphenyl)aminothiazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-(2-hydroxy-4-methylphenyl)aminothiazole: structure given in first source; cpd is also a free radical scavenger [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID163834
CHEBI ID34598
SCHEMBL ID2746827
MeSH IDM0172923

Synonyms (24)

Synonym
icoduline hydrochloride
cbs-113 a
cbs 113a
110952-54-0
phenol, 5-methyl-2-(2-thiazolylamino)-, monohydrochloride
2-(2-hydroxy-4-methylphenyl)aminothiazole
unii-frm2ibi8xa
frm2ibi8xa ,
m-cresol, 6-(2-thiazolylamino)-, monohydrochloride
cbs-113a
6-(2-thiazolylamino)-m-cresol monohydrochloride
2-(2-hydroxy-4-methylphenyl)aminothiazole hydrochloride
niosh/gp3140000
GP31400000
phenol, 5-methyl-2-(2-thiazolylamino)-, hydrochloride
SCHEMBL2746827
CHEBI:34598
5-methyl-2-(thiazol-2-ylamino)phenol
5-methyl 2-(2-thiazolylamino)phenol hydrochloride
phenol, 5-methyl-2-(2-thiazolylamino)-, hydrochloride (1:1)
DTXSID30911913
5-methyl-2-[(1,3-thiazol-2-yl)amino]phenol--hydrogen chloride (1/1)
Q27116170
5-methyl-2-(1,3-thiazol-2-ylamino)phenol;hydrochloride
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic molecular entityAny molecular entity that contains carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (42.86)18.7374
1990's4 (57.14)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.31 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (14.29%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]